StonvexLoading…
StonvexStonvexStonvexCore line items from PRGS's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-02-28 | Annual 2025 2025-11-30 | Q3 2025 2025-08-31 | Q2 2025 2025-05-31 |
|---|---|---|---|---|
Revenue | $247.80M | $977.83M | $725.16M | $475.37M |
Operating Income | $46.47M | $153.29M | $114.92M | $71.04M |
Net Income | $22.81M | $73.13M | $47.39M | $27.98M |
EPS (Diluted) | $0.53 | $1.66 | $1.07 | $0.63 |
Total Assets | $2.39B | $2.46B | $2.42B | $2.41B |
Total Liabilities | Not available | Not available | Not available | Not available |
Cash & Equivalents | $113.17M | $94.81M | $99.01M | $102.01M |
Free Cash Flow OCF − CapEx | $95.92M | $229.49M | $169.55M | $97.16M |
Shares Outstanding | 42.07M | 42.34M | 42.91M | 43.10M |